Evidence of TDP-43 loss of function, such as cryptic exon incorporation observed in Alzheimer’s disease (AD) brains that lack visible TDP-43 inclusions but show nuclear clearance of TDP-43, suggests that current detection tools may lack sufficient sensitivity to detect all relevant aggregation events14. This evidence concerns the gene TARDBP and Alzheimer disease.